Veronika Schmitt

Director of Product Development at Sustained Therapeutics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Vancouver, British Columbia, Canada, CA
Languages
  • English Full professional proficiency
  • German Native or bilingual proficiency
  • French Elementary proficiency
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Regulatory Affairs Certificate: Medical Devices and Pharmaceuticals (Dual)
    Regulatory Affairs Professionals Society (RAPS)
    Aug, 2018
    - Oct, 2024
  • General Principals of Rodent Surgery
    Centre for Comparative Medicine (UBC)
    Jan, 2011
    - Oct, 2024
  • Instructional Skills Workshop (ISW)
    UBC Centre for Teaching, Learning and Technology
    Jan, 2011
    - Oct, 2024
  • Pharmacy Licence
    Federal Union of German Associations of Pharmacists
    Jun, 2010
    - Oct, 2024
  • Biology and Husbandry of the Laboratory Rodent
    Centre for Comparative Medicine (UBC)
    Jan, 2009
    - Oct, 2024
  • Radionuclide Safety and Methodology
    University of British Columbia
    Jan, 2014
    - Oct, 2024

Experience

  • Sustained Therapeutics
    • Biotechnology Research
    • 1 - 100 Employee
    • Director of Product Development
      • Sep 2022 - Present
  • Vancouver Prostate Centre
    • Canada
    • Research Services
    • 1 - 100 Employee
    • Research Associate
      • May 2018 - Aug 2022

      My current project focuses on the advancement of various drug products from the preclinical to the clinical stageKeywords and skills: • Characterization of polymeric drug carriers (degradation behavior, rheological properties, drug release)• Clinical development • CMC • Supplier Management• Regulatory affairs/communication with Health Canada

    • Postdoctoral Fellow
      • Aug 2016 - May 2018

      Project: Polymeric Drug Formulations for the Treatment of Prostate Conditions• Formulation of polymeric drug carriers;• Assessment of in vitro and in vivo drug release;• HPLC- Analysis of complex drug mixtures;

  • The University of British Columbia
    • Canada
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Fellow
      • Jan 2016 - Jul 2016

      Project: Gallium-67 labeled hyperbranched polyglycerols (67-Ga-DFO-HPGs) as possible SPECT/CT imaging agents:• Injection of radiotracers into tumor mouse model;• SPECT and CT image generation using a preclinical small animal scanner (VECTor, MILabs);• Determination of the kinetics of the radiotracer using biodistribution and quantitative 3D image analysis (π.pmod, Biomedical Image Analysis Software);

    • Research Assistant
      • Mar 2011 - Dec 2015

      PhD Thesis: Sampling and pharmacokinetics of skin interstitial fluid for therapeutically monitored drugs:• Study of new sampling techniques for skin tissue fluid using vacuum, vibrations, filtration and microneedles;• Pharmacokinetics of drugs in blood and tissue fluid in a rabbit animal model;• LCMS-MS drug analysis for vancomycin using 2 µL of biological sample;

  • EPFL (École polytechnique fédérale de Lausanne)
    • Switzerland
    • Higher Education
    • 700 & Above Employee
    • Research Intern in Material Sciences
      • Apr 2010 - Sep 2010

      Project: Comparison of toxicity tests for HeLa cells incubated with superparamagnetic iron oxide nanoparticles (SPIONS): • Testing of cell toxicity of magnetic particles with variable surface groups ( -OH, -NH2, -COOH); • Determination of cell viability using different kits: Calcein AM cell viability assay, MTT and MTS assay, CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay, Mît-E- ΨTM Mitochondrial Permeability Detection Kit AK-116 ; • Quantification of iron updake into the cell; Show less

    • Research Intern in Pharmacology
      • May 2009 - Dec 2009

      Project: Interaction of cardiac lipoprotein lipase (LPL) with heparin-coated magnetic microparticles: • Retrograde-Langendorff perfusion of rat hearts to release LPL; • LPL quantification using a Tritium-labeled enzyme substrate (triolein); Project: Interaction of cardiac lipoprotein lipase (LPL) with heparin-coated magnetic microparticles: • Retrograde-Langendorff perfusion of rat hearts to release LPL; • LPL quantification using a Tritium-labeled enzyme substrate (triolein);

  • Ludwig-Maximilians-Universität (LMU) München
    • Student Researcher in Pharmaceutical Technology
      • Mar 2008 - Mar 2008

      Project: Preparation and stabilization of fenofibrate-nanosuspensions Project: Preparation and stabilization of fenofibrate-nanosuspensions

Education

  • The University of British Columbia / UBC
    Doctor of Philosophy (Ph.D.), Drug Delivery and Nanomedicine
    2011 - 2015
  • Ludwig-Maximilians Universität München
    Registered Pharmacist (Germany), Pharmacy
    2004 - 2009

Community

You need to have a working account to view this content. Click here to join now